HEALTHY VOLUNTEERS (HV)
Clinical trials for HEALTHY VOLUNTEERS (HV) explained in plain language.
Never miss a new study
Get alerted when new HEALTHY VOLUNTEERS (HV) trials appear
Sign up with your email to follow new studies for HEALTHY VOLUNTEERS (HV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Parkinson's drug enters first human safety trials
Symptom relief Recruiting nowThis study tests whether a new oral drug, AX-5006, is safe and tolerable in healthy adults and people with Parkinson's disease. It involves three parts: single doses, multiple doses over a week, and daily doses for 28 days. The goal is to gather safety data before larger trials.
Matched conditions: HEALTHY VOLUNTEERS (HV)
Phase: PHASE1 • Sponsor: Vertero Therapeutics • Aim: Symptom relief
Last updated May 18, 2026 12:00 UTC
-
New drug JADE101 first tested in healthy volunteers
Knowledge-focused Recruiting nowThis early-stage study tests a single dose of JADE101 in 40 healthy Japanese and Chinese adults aged 18-55. The main goal is to check safety and how the drug moves through the body. No treatment or health benefit is expected for participants.
Matched conditions: HEALTHY VOLUNTEERS (HV)
Phase: PHASE1 • Sponsor: Jade Biosciences, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 06:02 UTC
-
New drug HXN6005 put to the test in healthy volunteers
Knowledge-focused Recruiting nowThis early-stage study is testing a new drug called HXN6005 in 32 healthy adults aged 18 to 55. Participants receive a single dose of either HXN6005 or a placebo, then are monitored for side effects and how the drug moves through the body. The goal is to check safety and tolerabi…
Matched conditions: HEALTHY VOLUNTEERS (HV)
Phase: PHASE1 • Sponsor: Helixon Biotechnology (Suzhou) Co., Ltd • Aim: Knowledge-focused
Last updated May 22, 2026 13:50 UTC